Cargando…

Clinical Practice Guidelines for Hypophosphatasia*

Hypophosphatasia (HPP) is a rare bone disease caused by inactivating mutations in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP). Patients with HPP have varied clinical manifestations and are classified based on the age of onset and severity. Recently, enzyme replaceme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michigami, Toshimi, Ohata, Yasuhisa, Fujiwara, Makoto, Mochizuki, Hiroshi, Adachi, Masanori, Kitaoka, Taichi, Kubota, Takuo, Sawai, Hideaki, Namba, Noriyuki, Hasegawa, Kosei, Fujiwara, Ikuma, Ozono, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2020
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958520/ https://www.ncbi.nlm.nih.gov/pubmed/32029969 http://dx.doi.org/10.1297/cpe.29.9

Ejemplares similares

Clinical Practice Guidelines for Achondroplasia*
por: Kubota, Takuo, et al.
Publicado: (2020)

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene
por: Miura, Kohji, et al.
Publicado: (2013)

Endocrinological and phenotype evaluation in a patient with acrodysostosis
por: Ueyama, Kaoru, et al.
Publicado: (2017)

An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
por: Miura, Kohji, et al.
Publicado: (2012)

Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types
por: Okawa, Rena, et al.
Publicado: (2019)

4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts
por: Takeyari, Shinji, et al.
Publicado: (2020)

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report
por: Takeyari, Shinji, et al.
Publicado: (2019)

Current concepts in perinatal mineral metabolism
por: Ohata, Yasuhisa, et al.
Publicado: (2016)

A novel COL1A1 deletion/insertion pathogenic variant in a patient with osteogenesis imperfecta
por: Yamada, Chieko, et al.
Publicado: (2022)

A family with brachydactyly mental retardation syndrome with a missense variant in HDAC4
por: Takeyari, Shinji, et al.
Publicado: (2023)

Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study
por: Ohata, Yasuhisa, et al.
Publicado: (2023)

A patient with pachydermoperiostosis harboring SLCO2A1 variants with a history of differentiating from acromegaly
por: Nakano, Yukako, et al.
Publicado: (2023)

Wnt Signaling in Bone
por: Kubota, Takuo, et al.
Publicado: (2010)

Neonatal cholestasis can be the first symptom of McCune–Albright syndrome: A case report
por: Satomura, Yoshinori, et al.
Publicado: (2021)

Pathogenic variants of the GNAS gene introduce an abnormal amino acid sequence in the β6 strand/α5 helix of Gsα, causing pseudohypoparathyroidism type 1A and pseudopseudohypoparathyroidism in two unrelated Japanese families
por: Ohata, Yasuhisa, et al.
Publicado: (2022)

Pheochromocytoma complicated by cyanotic congenital heart disease: a case report
por: Yamamoto, Keiko, et al.
Publicado: (2016)

Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study
por: Kubota, Takuo, et al.
Publicado: (2020)

Molecular Bases of Diseases Characterized by Hypophosphatemia and Phosphaturia: New Understanding
por: Ozono, Keiichi, et al.
Publicado: (2006)

Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss
por: Kubota, Takuo, et al.
Publicado: (2006)

Clinical Characteristics of Perinatal Lethal Hypophosphatasia: A Report of 6 Cases
por: Nakamura-Utsunomiya, Akari, et al.
Publicado: (2010)

Therapeutic Use of Oral Sodium Phosphate (Phosribbon(®) Combination Granules) in Hereditary Hypophosphatemic Rickets
por: Ozono, Keiichi, et al.
Publicado: (2014)

Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report
por: Fukushima, Kazunori, et al.
Publicado: (2019)

Bisphosphonate Use and Fractures in Adults with Hypophosphatasia
por: Rassie, Kate, et al.
Publicado: (2019)

Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
por: Fujisawa, Yasuko, et al.
Publicado: (2020)

A Japanese Male Patient with ‘Fibular Aplasia, Tibial Campomelia and Oligodactyly’: An Additional Case Report
por: Kitaoka, Taichi, et al.
Publicado: (2009)

Phenotypes of a family with XLH with a novel PHEX mutation
por: Yamamoto, Akiko, et al.
Publicado: (2020)

Transformative therapy in hypophosphatasia
por: Bishop, Nick, et al.
Publicado: (2016)

Roles of Phosphate in Skeleton
por: Michigami, Toshimi, et al.
Publicado: (2019)

Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey
por: Fujiwara, Makoto, et al.
Publicado: (2013)

Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels
por: Koyama, Hiroyuki, et al.
Publicado: (2019)

Health-related Quality of Life in Adult Patients with Multiple Epiphyseal Dysplasia and Spondyloepiphyseal Dysplasia
por: Matsushita, Masaki, et al.
Publicado: (2021)

Inconvenience and adaptation in Japanese adult achondroplasia and hypochondroplasia: A cross-sectional study
por: Ajimi, Akiko, et al.
Publicado: (2021)

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature
por: Oyachi, Maki, et al.
Publicado: (2018)

A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a GALNT3 variant
por: Nishimura-Kinoshita, Naoko, et al.
Publicado: (2023)

A unique case of childhood hypophosphatasia caused by a novel heterozygous 51-bp in-frame deletion in the ALPL gene
por: Tachikawa, Kanako, et al.
Publicado: (2023)

A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa
por: Miura, Kohji, et al.
Publicado: (2011)

Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta
por: Ohata, Y., et al.
Publicado: (2019)

Correction to: Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta
por: Ohata, Y., et al.
Publicado: (2020)

Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice
por: Miyagawa, Kazuaki, et al.
Publicado: (2014)

SUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry
por: Kishnani, Priya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gur0shvkebfd9oqra5eoqcv0j5